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A freedom from disease study: Schmallenberg
virus in the south of England in 2015
Jessica Eleanor Stokes, Matthew Baylis, Jennifer Sarah Duncan
In 2011–2012, northern European livestock faced a threat from a newly emerged virus,
Schmallenberg virus (SBV), only a few years after a major outbreak of bluetongue serotype 8
(BTV-8). Like BTV-8, SBV is transmitted by Culicoides biting midges to ruminants and spread
throughout Europe. SBV, however, spread faster, reaching the UK within three months of
initial discovery. Adult ruminants show only mild, if any, clinical signs; however, infection of
naive ruminants by SBV during the vulnerable period of gestation leads to abortions,
stillbirths and fetal malformations. Although some data exist for the prevalence of SBV on UK
sheep farms early in the outbreak, we have no information on its current status. Is SBV still
circulating in the UK? To answer this, the authors designed a freedom from disease study
across the southernmost counties of the UK. During autumn 2015, 1444 sheep, from 131
farms, were tested for antibodies against SBV by ELISA; 5 samples from 4 farms were twice
found positive by ELISA but were later conﬁrmed negative by virus neutralisation test. As the
sheep were born between October 2014 and April 2015, the authors conclude that it is
unlikely that SBV is still circulating in the south of England.
In November 2011, a novel Orthobunyavirus, of the Simbu ser-
ogroup, was identiﬁed by metagenomic analysis of cattle pre-
senting with diarrhoea, hyperthermia and reduced milk yield in
Germany (Hoffmann and others 2012). The virus was subse-
quently named Schmallenberg virus (SBV), after the geographic
origin of the samples tested. SBV spread rapidly, reaching
England within three months of initial outbreak, with the
southernmost counties of England all reporting outbreaks of
SBV between 2012 and 2013 (EFSA 2012). Like several viruses of
the Simbu serogroup and the unrelated bluetongue virus sero-
type 8 (BTV-8), SBV is transmitted by Culicoides biting midges.
It is thought that the initial incursion into the UK was via wind
dispersal of SBV-infected Culicoides from France 113 days before
the ﬁrst report of a malformed lamb (Elbers and others 2013,
Sedda and Rogers 2013).
Since its initial discovery, SBV has been detected throughout
Europe (EFSA 2014) in domestic cattle, sheep, goats and numer-
ous species of wild ruminants, including camelids. Recently, a
high frequency of samples from hunted wild boar in Germany
were found to have SBV-speciﬁc antibodies (collected 2011/
2012) (Mouchantat and others 2015). Additionally, there is a
single report of SBV-speciﬁc antibodies in a dog, but other
studies have failed to ﬁnd evidence of infection in carnivores
(Wensman and others 2013, Mouchantat and others 2015).
European studies, conducted in 2011, 2012 and 2013, found
animal-level prevalence to range between 8 to 100 per cent and
8.5 to 93.3 per cent in cattle and sheep, respectively (Elbers and
others 2012, Gache and others 2013, Nanjiani and others 2013).
Herd-level prevalence of UK sheep in 2012/2013 was found to
range between 40 and 90 per cent (Nanjiani and others 2013).
SBV infections of adult ruminants are generally asymptom-
atic; however, if infection of a naive pregnant animal coincides
with the vulnerable period of gestation, transmission across the
placenta can result in abortions, stillbirths and fetal malforma-
tions (Beer and others 2013, Doceul and others 2013). Studies on
the related Akabane virus estimate the vulnerable period to be
between days 28 and 56 of pregnancy; however, a recent study
demonstrated high placental colonisation of SBV when infected
at days 45 or 60 of gestation, but a lack of subsequent abortions
and malformations observed in the lambs (EFSA 2012,
Martinelle and others 2015). Fetal or neonate malformations
typically present as arthrogryposis, scoliosis, kyphosis, severe
torticollis, brachygnathia and hypoplasia of the central nervous
system (Doceul and others 2013). The hypoplasia may be mild
to severe, resulting in microencephaly, hydranencephaly and
spinal cord and cerebellar hypoplasia (van den Brom and others
2012, Doceul and others 2013). Behavioural and/or neurological
disorders are also frequently noted, with lung hypoplasia some-
times observed (Lievaart-Peterson and others 2012). In the case
of twins, it is possible for only one to present with malforma-
tions, while the other remains viable, or for one twin to present
with arthrogryposis, whereas the other presents neurologically
(Doceul and others 2013).
A recent study on the duration of immunity in experimen-
tally infected adult sheep has demonstrated SBV-speciﬁc IgG
antibodies detectable for over one year after a single challenge
with SBV (Poskin and others 2015). Additional evidence exists of
acquired immunity against reinfection in naturally infected
sheep, as well as evidence of maternally derived antibodies in
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suckling lambs (Rodríguez-Prieto and others 2014). While experi-
mentally infected cattle have been demonstrated to remain
immune to reinfection for at least 56 days (Wernike and others
2013).
Four cases of SBV were conﬁrmed on January 16, 2012
(Harris and others 2014). Voluntary reporting recorded 81 and 87
serologically conﬁrmed cases in UK sheep in 2012 and 2013,
respectively (AHVLA 2013); however, no cases of SBV were con-
ﬁrmed by PCR in lambs or calves presenting with arthrogryposis
by the Animal and Plant Health Agency (APHA) in 2014 or 2015
(APHA, personal communication). A recent study of naive cattle
from the Netherlands detected a low level of SBV (<1 per cent)
in 2013 (Veldhuis and others 2015). A German study reported a
recurrence of SBV in cattle in 2014, despite an apparent decrease
in cases the previous year (Wernike others 2015).
The high circulation of SBV in the UK in 2012 and 2013 fol-
lowed by a subsequent decline in cases in 2014 and 2015 leads to
the following question; is this apparent decline in cases in the
UK a true decrease in circulation or a lack of reporting? This
study aimed to determine whether SBV was still circulating in
the southernmost counties of England in 2015 by examining the
serological status of sheep born after the 2014 vector period.
Materials and methods
All animal work was reviewed and approved by the University
of Liverpool internal ethics committee (VREC310) and carried
out under a Home Ofﬁce Project Licence (PPL 70/8529). All
farmers gave informed written consent and were reminded of
their right to withdraw from the study at any point.
To calculate the number of farms needed to substantiate a
prevalence of 2.5 per cent or below the software package, FFD
was implemented in R (Kopacka 2011). As sheep occur within
ﬂocks, a two-stage cluster analysis was used to estimate both
the number of ﬂocks and the number of sheep within each ﬂock
to be sampled; individual sampling was selected to allow the
test sensitivity to remain the same across ﬂocks. The α-error
threshold was set to 0.05 (5 per cent). An intraherd prevalence of
20 per cent was set, which is lower than the prevalence recorded
in several large-scale continental studies, but closer to the lower
range reported in a 2013 UK study (Elbers and others 2012,
Nanjiani and others 2013, Veldhuis and others 2013, Méroc and
others 2013b); herd sensitivity of Seherd=90% was set (EFSA
2014), with a known test sensitivity of Se2=97.2% (Bréard and
others 2013). The total number of sheep holdings in the south-
ernmost counties of England was extracted from the
Department for Environment, Food & Rural Affairs (DEFRA)
2010 census: a total of 6495 sheep holdings were registered. This
determined a necessary sample size of 11 sheep per holding col-
lected from 131 holdings to detect prevalence below 2.5 per cent
with 95 per cent conﬁdence. Holdings were recruited for the
study through the National Sheep Association (NSA) South
West show, NSA magazine and large animal veterinary practices
(Fig 1). The number of holdings sampled per county was strati-
ﬁed based on DEFRA 2010 census data: Cornwall (n=18), Devon
(n=67), Dorset (n=12), Hampshire (n=5), Sussex (n=20) and
Kent (n=9).
Blood samples were collected between September 15, 2015,
and December 11, 2015, from the jugular vein of 12 sheep per
holding (11, plus 1 to account for failures). Sampling began after
the spring and summer peaks in midge activity, with the major-
ity of samples collected after the ﬁnal autumn peak in midge
activity (Sanders and others 2011). All sampled sheep were born
after October 2014 and were more than six months old at time
of sampling to exclude animals with immunity following infec-
tion in 2012, 2013 or 2014 and to avoid maternal antibodies.
This assumption is based on the maternal antibodies of calves
lasting less than six months for both SBV and Akabane virus
(Tsutsui and others 2009, Elbers and others 2014). Serum was
FIG 1: Map of the south of England showing the distribution of sampled farms. Exact farm location has been jittered and enlarged to prevent
individual participant identiﬁcation. Ten farmers asked that their farm location was not mapped
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extracted from the blood samples and analysed by a commer-
cially available SBV antibody ELISA (ID Screen SBV indirect,
IDvet, France) as per the manufacturer ’s instructions. Serum
samples were considered negative if the S/P% (sample to positive
percentage) was up to 50 per cent calculated as per manufac-
turer ’s instructions. Samples returning an S/P% greater than 50
per cent were sent to the APHA to be conﬁrmed by a virus neu-
tralisation test (VNT). An equal number of samples returning an
S/P% less than 50 per cent were also sent as blind controls; they
were selected randomly using the RANDBETWEEN function in
Microsoft Excel to determine farm number and then sample
number from farm. Two positive controls were used in the VNT,
with VNT titres of 1/40 and 1/80, respectively. Samples were
determined to be negative if the VNT titre was greater than 1/5
based on the minimum dilution undertaken at the APHA (La
Rocca, personal communication).
Results
A total of 1572 sheep from 131 holdings were sampled between
September 15 and December 11, 2015. Flock sizes ranged from
20 to 5000, all sheep sampled were born between October 2014
and April 2015. Of the 131 holdings sampled, 103 were lowland
ﬂocks, 8 hill, 8 upland, 10 had ﬂocks across lowland, hill and/or
upland pastures and 2 holdings declined to answer or were
unsure.
Half (50.0 per cent) of farmers (57/124, seven farmers
declined to answer) reported that they had previously suspected
cases of SBV infection in their ﬂocks in the form of birth of
lambs showing typical congenital abnormalities. Of these 57
farmers, 12 had cases that were diagnosed by a vet but not
laboratory conﬁrmed, while 13 had cases that were diagnosed by
a vet and laboratory conﬁrmed as SBV. In the remaining 32
suspect case farms, none had disease diagnosed, either by a vet
or laboratory.
Only 13.7 per cent (17/124) of farmers stated that they had
vaccinated their sheep against SBV; 15 farmers stated they vacci-
nated in 2013, while 2 farmers vaccinated in both 2013 and
2014. One farmer vaccinated only their cattle against SBV but
not their sheep.
By contrast, only 1.6 per cent (2/124) of the farmers stated
that they had had cases of BTVon farm, with 78.2 per cent (97/
124) stating that they had vaccinated against BTV for at least
one year.
A total of 11 sheep from each holding were tested by ELISA
for antibodies against SBV (1444 samples in total). Overall nine
samples, from eight holdings, returned doubtful or positive (S/P
per cent > 50 per cent) results for antibodies to SBV when
tested by ELISA. These samples were retested by ELISA, with
ﬁve samples, from four holdings returning positive for antibodies
against SBV. No antibodies were detected in these ﬁve samples
when tested by VNTat the APHA (Table 1).
Discussion
This study found it unlikely that any antibodies against SBV
were circulating in the sheep tested. As these sheep were born
between October 2014 and May 2015, we can be 95 per cent
conﬁdent that if SBV was circulating in the south of England in
the 2015 vector period, it was present below the 2.5 per cent
prevalence threshold designed by this study. Using a similar
testing procedure, a study of cattle in the Netherlands deter-
mined a maximum possible prevalence of herds to be <1 per
cent prevalence in 2013 (Veldhuis and others 2015).
The speciﬁcity of the commercial ELISA kit used was
reported to be 99.8 per cent, giving a likely false-positive rate of
∼3 samples of the 1444 tested. Initially 9 out of the 1444
samples returned positive by ELISA for SBV-speciﬁc antibodies,
higher than the calculated test false-positive rate. However,
other studies have cast doubt on the high speciﬁcity of the test if
the virus is circulating below the peak outbreak levels, with a
false-positive rate of 41 per cent reported in wild cervids (Laloy
and others 2014) tested by both the indirect ELISA used here and
the VNT (Bréard and others 2013, Laloy and others 2014). The
use of VNTs as conformational tests for commercial ELISAs is
considered advisable due to the high (∼99–100 per cent) sensitiv-
ity and speciﬁcity of the VNT (Loeffen and others 2012).
As observed during the height of the SBVoutbreak in Europe,
the transmission of SBV is highly efﬁcient, spreading rapidly
both within and between ﬂocks (Veldhuis and others 2013,
Méroc and others 2013a, EFSA 2014, Wernike and others 2014).
This spread was far faster than that of BTV-8, likely due to the
much shorter viraemia, much higher probability of host to
vector transmission and SBV’s predicted faster replication rate
and replication at a lower temperature threshold than BTV-8
(Gubbins and others 2014). Even with low levels of SBV circula-
tion and few susceptible hosts on farm, previous studies have
demonstrated eventual seroconversion of these individuals
(Elbers and others 2013). These characteristics of SBV make it
also highly unlikely that the ﬁve ELISA-positive samples were
true positives as that would mean SBV was persisting at a very
low prevalence, within a large naive population. However, this
TABLE 1: Schmallenberg virus (SBV) ELISA and virus neutralisation test (VNT) results in samples that returned a positive ELISA test
result, holding ID, county of farm, breed of sheep, birth and sample dates, ELISA titre (S/P%), VNT result, previous self-reporting
of suspected cases on farm by farmer and if the farm vaccinated against SBV in 2013
Sheep







SBV cases on farm?
Vaccinated flock
against SBV in 2013
1 21 Dorset Texel March 2015 September 2015 166.55* 9.82† Not Tested No Yes
2 25 Dorset Poll Dorset January 2015 September 2015 64.93* 46.40† Not Tested No No
3 46 Hampshire Hampshire December 2014 October 2015 60.77* 44.41† Not Tested Yes‡ No
4 48 Cornwall Roussin February 2015 October 2015 55.43* 39.54† Not Tested Yes No
5 59 Devon Highlander March 2015 October 2015 78.14* 120.62* Negative No No
6 108 Sussex Dorset February 2015 November 2015 110.32* 80.97* Negative Yes‡ No
7 113 Sussex Charolais February 2015 November 2015 90.61* 127.66* Negative Yes No
8 113 Sussex Charolais February 2015 November 2015 66.45* 125.91* Negative
9 121 Cornwall Lleyn X Texel March 2015 November 2015 117.97* 123.79* Negative No No
10 12 Devon Poll Dorset December 2014 September 2015 3.19† Not Tested Negative Yes No
11 50 Cornwall Zwartble March 2015 October 2015 3.93† Not Tested Negative No No
12 99 Kent Charolais March 2015 November 2015 8.46† Not Tested Negative Yes No
13 106 Sussex Charolais March 2015 November 2015 2.50† Not Tested Negative Yes‡ No
14 115 Sussex Southdown X
Dorset
April 2015 November 2015 5.18† Not Tested Negative Yes‡ No
Samples 10–14 are negative controls for the VNT
*ELISA positive S/P%
†ELISA negative S/P%
‡Laboratory-confirmed cases of SBV on farm
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does not mean that it is impossible for SBV to persist at very
low levels, particularly if reintroduced late in the Culicoides
season, as the current knowledge of the epidemiology of SBV is
still expanding.
Despite this, surveillance for SBV should continue, with a
German study describing a decline of SBVoccurrence in cattle in
2013 compared with 2011–2012 seroprevalence, followed by an
increase in cases the following year (Wernike and others 2015).
This is a frequent occurrence with midge-borne arboviruses. For
example, since the end of the most recent BTV-8 outbreak, the
serotype was considered absent from France, with disease-free
status granted in 2012; only for it to re-emerge in August 2015
(Sailleau and others 2015). It has been postulated that this new
outbreak may have re-emerged from wildlife reservoirs, with red
deer in Spain previously testing positive for BTV when local live-
stock remained disease free (Ruiz-Fons and others 2014). If this
was indeed the case, then greater emphasis should be put on sur-
veillance of wild ruminant populations to determine freedom
within this potential reservoir source, particularly as far more
wild species have been demonstrated to have SBV-speciﬁc anti-
bodies, with far higher prevalence in populations described, than
for BTV-8 (Rossi and others 2015). An alternative to invasive
on-farm procedures would be the widespread trapping of
Culicoides for surveillance, perhaps by bulk testing by county/
canton to rapidly test large numbers of the insects (Poskin and
others 2016). Targeted surveillance could also be used, collecting
Culicoides at sites deemed ‘high risk’ for possible passive wind
transfer from Europe, particularly in the event of recurrence on
the continent.
Regardless of the current status of SBV in Europe, this study
has highlighted a large, naive population, susceptible to future
potential outbreaks within the south of England. Effective sur-
veillance systems are therefore needed to warn vets and farmers
of future disease risks.
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